About Lonza Group AG 
Lonza Group AG
Pharmaceuticals & Biotechnology
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
Company Coordinates 
Company Details
Muenchensteinerstrasse 38 , BASEL None : 4002
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 9 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Albert Baehny
Chairman of the Board, Member of the Executive Board
Mr. Christoph Maeder
Lead Independent Member of the Board
Prof. Dr.-Ing. Werner Bauer
Independent Member of the Board
Ms. Angelica Kohlmann
Independent Member of the Board
Ms. Barbara Richmond
Independent Member of the Board
Mr. Juergen Steinemann
Independent Member of the Board
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
Pharmaceuticals & Biotechnology
CHF 38,907 Million ()
48.00
NA
0.77%
0.43
9.46%
4.51






